Efficacy and safety of sildenafil added to pirfenidone in patients with advanced idiopathic pulmonary fibrosis and risk of pulmonary hypertension: a double-blind, randomised, placebo-controlled, phase 2b trial-Reference-Cited by-同舟云学术

Efficacy and safety of sildenafil added to pirfenidone in patients with advanced idiopathic pulmonary fibrosis and risk of pulmonary hypertension: a double-blind, randomised, placebo-controlled, phase 2b trial

Published:2021-01 Issue:1 Volume:9 Page:85-95
ISSN:2213-2600
Container-title:The Lancet Respiratory Medicine
language:en
Short-container-title:The Lancet Respiratory Medicine

Author:

Behr Jürgen,Nathan Steven D,Wuyts Wim A,Mogulkoc Bishop Nesrin,Bouros Demosthenes E,Antoniou Katerina,Guiot Julien,Kramer Mordechai R,Kirchgaessler Klaus-Uwe,Bengus Monica,Gilberg Frank,Perjesi Andras,Harari Sergio,Wells Athol U

Publisher

Elsevier BV

Subject

Pulmonary and Respiratory Medicine

Reference30 articles.

1. Cancer statistics, 2019;Siegel;CA Cancer J Clin,2019

2. Clinical course and prediction of survival in idiopathic pulmonary fibrosis;Ley;Am J Respir Crit Care Med,2011

3. Pirfenidone in patients with idiopathic pulmonary fibrosis (CAPACITY): two randomised trials;Noble;Lancet,2011

4. A phase 3 trial of pirfenidone in patients with idiopathic pulmonary fibrosis;King;N Engl J Med,2014

5. Efficacy and safety of nintedanib in idiopathic pulmonary fibrosis;Richeldi;N Engl J Med,2014

Cited by 90 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Predicting biomarkers related to idiopathic pulmonary fibrosis: Robust ranking aggregation analysis and animal experiment verification;International Immunopharmacology;2024-09

2. A Case of Interstitial Lung Disease-Related Pulmonary Hypertension Successfully Treated with Inhaled Iloprost;Life;2024-08-27

3. Use of pirfenidone in fibrotic interstitial lung diseases and beyond: a review;Frontiers in Medicine;2024-08-06

4. Exploring the causal effect between lipid-modifying drugs and idiopathic pulmonary fibrosis: a drug-target Mendelian randomization study;Lipids in Health and Disease;2024-08-01

5. Evidence from recent clinical trials in fibrotic interstitial lung diseases;Current Opinion in Pulmonary Medicine;2024-07-04